Explore a curated atlas of rare diseases with genomic insights, expert analyses, and patient-driven narratives designed for international researchers and families navigating rare conditions.
Global Disorders390+
Genome Records120K+
Research Partners45 Countries
RGeneLib bridges advanced genomics and compassionate care. Our mission is to deliver accurate, updated, and culturally sensitive information on rare diseases, empowering clinicians, researchers, and families worldwide.
Integrating genomic datasets, case reports, and clinical trials across continents.
Highlighting lived experiences, support communities, and advocacy pathways.
Discover curated overviews of rare genetic conditions with phenotypic markers, diagnostic criteria, and therapeutic pipelines.
Mutation-specific therapy landscape, CFTR gene variants, and precision nutrition insights.
Read Full Insight →Enzyme replacement therapies, type-specific biomarkers, and ancestry-linked prevalence.
Explore Data Brief →Polyglutamine repeat profiling, emerging gene-silencing trials, and care models.
Open Clinical Dossier →Meet Amara, living with spinal muscular atrophy in Nairobi. Her cross-border care team leveraged tele-genetics, remote physiotherapy, and family-led advocacy to shape an independent life.
Read Amara's Journey →Monthly multilingual sessions connecting caregivers, clinicians, and advocates.
Peer-to-peer pairing program offering emotional support and resource navigation.
Micro-grants for travel, assistive devices, and localized genetic counseling.
Stay ahead with curated publications, funding calls, and translational breakthroughs across rare disease communities.
Multi-national consortium reports promising neuronal rescue in preclinical models.
View Trial Snapshot →Computer vision and genomic analytics accelerate rare disease identification.
Read Research Brief →Proteomic signatures identified for early intervention pathways.
Inspect Data Story →Contribute datasets, co-design clinical trials, and amplify advocacy efforts with an inclusive network of rare disease champions.
We prioritize ethical data stewardship and equitable knowledge sharing.